Intestinal spirochetosis: an unusual cause of IBD flare-up during anti-TNF therapy
Intestinal spirochetosis: an unusual cause of IBD flare-up during anti-TNF therapy
复制标题
肠螺旋体病:抗 TNF 治疗期间 IBD 发作的一个不寻常原因
DOI:
--
复制
发表时间:
2016
影响因子:
2.8
通讯作者:
H. Pinheiro
中科院分区:
文献类型:
--
作者:
J. Chebli;Nathalia Chebli de Abreu;L. Chebli;M. Reboredo;H. Pinheiro
Dear Editor: Combination therapy with infliximab and azathioprine has proven to be more effective for induction and maintenance treatment of moderate-to-severe inflammatory bowel diseases (IBDs) over at least 1 year than either agent alone [1]. However, there has been concern about a higher risk of infection associated with concomitant use of immunomodulator with anti-TNF therapy. Disease flares during maintenance antiTNF therapy on IBD patients may be due to secondary loss of response, fibrostenosis, obstruction, superinfection, especially caused by Clostridium difficile or cytomegalovirus, or a problem that is not IBD-related [2]. To the best of our knowledge, intestinal spirochetosis (IS) causing IBD flare-up during anti-TNF therapy has never been reported. A 35-year-old woman presented to our gastroenterology outpatient clinic with a 6-week history of abdominal pain associated with watery diarrhea. She had been diagnosed with severe steroid refractory Crohn’s ileocolitis 15 months prior and had been managed successfully with combination therapy with infliximab and azathioprine. The patient remained in clinical remission on combined therapy for 10 months subsequently. In the last 6 weeks, the patient became ill again, with a flare in bowel symptoms featured by intermittent episodes of right lower-quadrant abdominal pain accompanied by two to five episodes a day of loose, watery, urgent stools. There was no vomiting, nausea, fever, skin rash, weight loss, or recent antibiotic exposure. Stool cultures for conventional enteric pathogens (Salmonella, Shigella, Campylobacter) and ova/ parasites were negative, as well as three stool tests for C. difficile toxin. Additional laboratory tests were unremarkable, including inflammatory markers (CRP and fecal calprotectin) and a negative HIV1/2 antibody test. A CT enterography only showed mild thickening of the distal terminal ileum, with no active disease in other areas of the bowel. A colonoscopy was performed and showed normal colonic mucosa throughout all segments and a normal-appearing terminal ileum. Random colon biopsies demonstrated focal increase in intra-epithelial lymphocytes and extensive end attachment of densely packed spirochetes to the epithelial surface in hematoxylin and eosin stain, confirmed by silver stain, particularly in cecum. No viral inclusions were identified. IS complicating immunosuppressant therapy was diagnosed, and the patient was treated with metronidazole (500 mg q.i.d. for 10 days) and kept on combined therapy with infliximab and azathioprine. Complete resolution of the symptomswas observed and sustained for more than 12 months after antibiotic treatment. The patient underwent the follow-up colonoscopy 6 months after the course of metronidazole, which revealed no abnormality. Random colonic biopsies showed no evidence of spirochetes. This is a case of Crohn’s disease flare caused by intestinal spirochetes superinfection in the setting of biologic maintenance therapy combined with immunosuppressant drug. IS is a condition in which colorectal epithelial cells are colonized and/or infected by spirochetes [3]. Spirochetosis occurs mainly in men who have sex with men and HIV-infected patients [4]. The most common symptoms are chronic watery diarrhea or * Julio Maria Fonseca Chebli chebli@globo.com
影响因子:
29.4
作者:
Hazlewood, Glen S.;Rezaie, Ali;Kaplan, Gilaad G.
通讯作者:
Kaplan, Gilaad G.